Literature DB >> 10392272

Experience with emergency cardiac surgery following institution of percutaneous cardiopulmonary support.

N Mitsui1, T Koyama, A Marui, T Mochizuki, Y Hayashi.   

Abstract

Between August 1992 and February 1998, 43 patients were treated with percutaneous cardiopulmonary support (PCPS) in our institution, and 8 of them subsequently required emergency cardiac surgery. There were 3 males and 5 females with a mean age of 63 years (range, 37 to 81 years). The etiology of shock in these 8 patients was acute myocardial infarction in 3, postinfarction left ventricular (LV) free wall rupture in 1, postinfarction ventricular septal perforation (VSP) in 1, LV free wall rupture and VSP in 1, and fatal arrhythmia due to severe aortic valvular disease in 2. The mean time interval from the onset of cardiogenic shock to the institution of PCPS was 77 min (range, 18 to 183 min). The mean time interval from the institution of PCPS until surgery was 145 min (range, 40 to 603 min). The surgical procedures were coronary artery bypass grafting (CABG) in 3 patients, closure of the LV rupture and/or closure of VSP in 3, and aortic valve replacement in 2. Six patients were weaned from PCPS, and 2 patients were discharged from the hospital (discharge rate, 25%). Although the results of emergency cardiac surgery following PCPS still are not satisfactory, we continue to apply PCPS and perform appropriate surgical procedures to improve the survival rate of the patients who would die without PCPS.

Entities:  

Mesh:

Year:  1999        PMID: 10392272     DOI: 10.1046/j.1525-1594.1999.06389.x

Source DB:  PubMed          Journal:  Artif Organs        ISSN: 0160-564X            Impact factor:   3.094


  1 in total

1.  Successful emergency aortic valve replacement following percutaneous cardiopulmonary support for the patient with aortic stenosis and cardiac arrest.

Authors:  Hironori Matsuhisa; Nobuhiko Mukouhara; Hidefumi Obo; Keitaro Nakagiri; Shuichi Kozawa; Tsutomu Shida
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2003-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.